Current Pharmaceutical Design

Papers
(The H4-Index of Current Pharmaceutical Design is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Analysis of the Growth and Development of Children Born with ICSI of Epididymal and Testicular Spermatozoa: A Propensity Matching Study77
Protective Effects of the Aqueous Extract of Malva sylvestris Plant against the Lethality and Histopathological Damage in Experimental Envenoming of Hemiscorpius lepturus Venom in Balb/c74
Molecularly Imprinted Polymers (MIPs): A Multifaceted Tool in Modern Analysis70
Drug Release and Stability Study of Innovated Losartan Potassium and Rosuvastatin Calcium Fixed-dose Combination Tablet65
Cytokines as Potential Therapeutic Targets and their Role in the Diagnosis and Prediction of Cancers65
Novel Approaches to the Management of Diabetes Mellitus in Patients with Coronary Artery Disease60
Computational Exploration of Flavonoids as HCV NS3/4A Protease Inhibitors: Advancing Antiviral Therapies to Mitigate Liver Cancer Risk56
Rosuvastatin Improves Endothelial Dysfunction in Diabetes by Normalizing Endoplasmic Reticulum Stress via Calpain-1 Inhibition47
Immune-mediated Bowel Disease: Role of Intestinal Parasites and Gut Microbiome45
Salivary Antiviral and Antibacterial Properties in the Encounter of SARS-CoV-245
Phytoestrogens: A Promising Therapeutic Approach for Endometriosis Management, Insights from Preclinical and Clinical Studies42
Mendelian Randomization Study on Serum Metabolites and Diabetic Nephropathy Risk: Identifying Potential Biomarkers for Early Intervention40
Treatment Options in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders39
CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis39
A Hydrogel for Nitric Oxide Sensitization Chemotherapy Mediated by Tumor Microenvironment Changes in 3D Spheroids and Breast Tumor Models39
Non-synonymous Single Nucleotide Polymorphisms in Human ACE2 Gene May Affect the Infectivity of SARS-CoV-2 Omicron Subvariants38
The Progress of Immune Cells-induced Inflammatory Response in Gout38
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies36
Topoisomerase Enzyme Inhibitors as Potential Drugs Against Cancer: What Makes Them Selective or Dual? – A Review35
The Potential Mechanism of Liujunzi Decoction in the Treatment of Breast Cancer based on Network Pharmacology and Molecular Docking Technology34
Associations Between microRNA-related Genetic Polymorphisms and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients34
Is Adrenaline Always the First Choice Therapy of Anaphylaxis? An Allergist-cardiologist Interdisciplinary Point of View32
Nanoparticles in CNS Therapeutics: Pioneering Drug Delivery Advancements30
ITGA9: Potential Biomarkers and Therapeutic Targets in Different Tumors30
Computational Approaches to Designing Antiviral Drugs against COVID-19: A Comprehensive Review30
Impact of Combination Therapy with Chemical Drugs and Megavoltage X-ray Exposure on Breast Cancer Stem Cells’ Viability and Proliferation of MCF-7 and MDA-MB-231 Cell Lines28
Traditional Uses, Phytochemistry, and Pharmacological Activities of Coleus amboinicus: A Comprehensive Review28
Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights28
0.33695101737976